.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Julphar
Fuji
Daiichi Sankyo
Covington
Queensland Health
Farmers Insurance
Boehringer Ingelheim
Healthtrust
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

MEN'S ROGAINE Drug Profile

« Back to Dashboard

When do Men's Rogaine patents expire, and what generic alternatives are available?

Men's Rogaine is a drug marketed by Johnson And Johnson and is included in one NDA. There is one patent protecting this drug.

This drug has eighteen patent family members in eleven countries.

The generic ingredient in MEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Drug patent expirations by year for MEN'S ROGAINE

Medical Subject Heading (MeSH) Categories for MEN'S ROGAINE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Johnson And JohnsonMEN'S ROGAINEminoxidilAEROSOL, FOAM;TOPICAL021812-001Jan 20, 2006OTCYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MEN'S ROGAINE

Country Document Number Estimated Expiration
Brazil9909796► Subscribe
AustraliaPP310798► Subscribe
Australia3323299► Subscribe
Japan2002512192► Subscribe
Spain2268856► Subscribe
Australia757601► Subscribe
Denmark1073439► Subscribe
Japan2007137899► Subscribe
Austria331517► Subscribe
European Patent Office1695708► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Queensland Health
Cantor Fitzgerald
Medtronic
Accenture
Colorcon
Daiichi Sankyo
Johnson and Johnson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot